A trial designed and co-ordinated by the Cancer Research UK Clinical Trials Unit to test an experimental drug in patients with head and neck cancer has launched today through the Combinations Alliance.
The University of Birmingham has partnered with Leuka, NHS Blood and Transplant and Anthony Nolan to deliver the UK's first large-scale clinical trials programme, to save and improve the lives of children and adults who receive stem cell transplants.
Cancer Research UK has awarded the University of Birmingham £1.5 million to fund a five-year research programme aimed at finding new treatments for bowel cancer.
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment.
A scientist at the University of Birmingham has received a £1.4 million award from Cancer Research UK to carry out pioneering research that may discover how cancer 'steals the keys' from the body's locksmiths, disrupting healthy cell growth and function.
Professor Dion Morton, Director of the Experimental Cancer Medicine Centre at the University of Birmingham, writes for the NIHR Blog on how the NIHR health research system has supported innovative research in his area of cancer surgery.
The College of Medical and Dental Sciences is delighted to announce that at the University of Birmingham Founders' Awards for Excellence 2017, held on Thursday 12 July during the Chancellor's Dinner, colleagues from across the College were awarded three of the evening's four awards.
The National Institute for Health Research (NIHR) has awarded £7 million to the Universities of Birmingham, Edinburgh and Warwick to establish a joint research unit focussed on developing global surgical research.
Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progression of the disease, according to new research by the Universities of Birmingham and Oxford.
Researchers at the University of Birmingham have found that a type of protein could hold the secret to suppressing the growth of breast cancer tumours.